i.dumitru

TL2 · Izmir

Contributes reviews on supplier material. Based in Izmir.

Joined 31 January 2025 · last posted 4d

79Posts here

2Topics

1Solutions

1.1kLikes received

965Likes given

24Badges

183Days visited

2.9kPosts read

Recent activity

Full stream

A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #92 · Practice › Interactions · 24 Jul 2026 · 26 likes I would keep widely repeated interaction claim and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
Shoulders, tangent skims, and defensible integration Replied, post #18 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 11 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Method validation is the demonstration that a method can separate…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #41 · Pharmacology › Formulation chemistry · 17 Jul 2026 · 1 like Post #39 is right about the mechanism and I think understates the practical bit. Small methodological point on Solubility limits: repeating a measurement is cheap and…
Coming back to: A structured critique template this community uses Replied, post #58 · Evidence › Study critique · 14 Jul 2026 · 2 likes Post #57 answers the question as asked. The question underneath it is different. Genuine question rather than a rhetorical one: has anyone here actually observed…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #57 · Practice › Dosing & titration · 12 Jul 2026 · 4 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #6 · Compounds › Tirzepatide · 11 Jul 2026 · 2 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #119 · Practice › Reconstitution · 10 Jul 2026 · 4 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
A critique that turned out to be unfair, retracted by its author Replied, post #21 · Evidence › Study critique · 30 Jun 2026 · 14 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. Where a critique changes your position, saying so in the thread is…
Restarting after a long gap: what the labelling implies Replied, post #2 · Practice › Dosing & titration · 25 Jun 2026 · 6 likes Coming back to the opening post, because the follow-up matters more than the original answer. Split dosing within a week is sometimes proposed to smooth tolerability.…
Follow-up: Reading an interaction checker output critically Replied, post #12 · Practice › Interactions · 20 Jun 2026 · 0 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
Tracking a shortage from primary sources rather than rumour Replied, post #50 · Access › Shortages · 14 Jun 2026 · 5 likes Narrowing post #49, because the general version has more than one answer. Counterpoint on tracking a shortage, offered without confidence: the same observation is…
Injecting into an area that has become firm: why not to Replied, post #65 · Practice › Administration · 13 Jun 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.